Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery

NCT00331838 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

705

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Semuloparin sodium
DRUG: Placebo (for Enoxaparin sodium)
DRUG: Enoxaparin sodium
DRUG: Placebo (for Semuloparin sodium)

Sponsor

Sanofi